Cyclodextrin complexation methods for formulatiing peptide proteasome inhibitors

摘要

This disclosure provides methods for formulating compositions comprising one or more peptide proteasome inhibitors, in particular carfilzomib, and a cyclodextrin, particularly a substituted cyclodextrin. Such methods substantially increase the solubility and stability of these proteasome inhibitors and facilitate both their manufacture and administration.